Skip to content

LazulEye

by S.A.L.F. S.p.A. Laboratorio Farmacologico Italy EUDAMED

Ref MBPS0201

EMDN Q02030201

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number805274210LazEyeVQ Basic UDI-DIDate11 Oct 2022RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • EPT 0477.MDR.22/4913.1 Reissued

    Quality management system EU MDR

    Notified body
    Notified body 0477
    Issued
    5 Oct 2022
    Expires
    3 Aug 2027

Specification

EUDAMED · synced 22 Oct 2026

Model / Reference
MBPS0201
Primary DI / UDI-DI
08052742102896
Basic UDI-DI
805274210LazEyeVQ
Unit of Use DI
18052742102893
EMDN Code
Q02030201 Ophthalmic dyes
Device Class
Class IIa
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000010720

Other devices from S.A.L.F. S.p.A. Laboratorio Farmacologico

  • Eparina sodica S.A.L.F.

    Class III
  • SalineSlush

    Class IIa
  • MethyBlue

    Class IIa
  • Servator H

    Class III
  • Pancreas LOCK S.A.L.F.

    Class IIb
  • Servator C

    Class III

See all devices from S.A.L.F. S.p.A. Laboratorio Farmacologico →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
Other properties (12)
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 5f1dadb7-b72a-4d48-bcdf-19b4074122b9 61 fields · synced 22 Oct 2026